The IRS wants people to take action by noon Wednesday if they want a shot at receiving coronavirus stimulus cash more quickly via direct deposit.
from Yahoo Finance https://ift.tt/2SZgMlk

The Afterpay Ltd (ASX: APT) share price was on form again on Monday and charged notably higher.
At one stage the payments company’s shares were up over 9% to a record high of $43.68.
This means that Afterpay’s shares have gone from a 52-week low of $8.01 on March 23 to a new record high in just seven weeks.
To put that into context, if you had been brave enough to invest $10,000 into Afterpay’s shares at its low, your investment would have been worth $54,500 on Monday.
There have been a couple of catalysts for Afterpay’s strong gains over the last seven weeks.
The first catalyst was a third quarter update which quashed concerns that the company’s buy now pay later platform would struggle during the current crisis.
During the third quarter the company delivered underlying sales of $2.6 billion, up 97% on the prior corresponding period. This was driven by a 40% lift in ANZ sales, a 263% increase in US sales, and a $0.1 billion contribution by the UK business.
But arguably best of all was its gross losses metric. This remained in line with the first half at 1%, which was particularly positive given the crisis and the increased contribution from newer markets that traditionally have initially higher losses early in the lifecycle.
This was achieved partly by its pre-emptive adjustments to risk settings, such as paying your first instalment up front, and increasing repeat customers.
The second catalyst for its strong share price gain was news that Tencent Holdings has become a substantial shareholder.
Investors appear optimistic the US$500 billion WeChat owner will be the key to opening up the Asian market in the future.
Management certainly sees a lot of positives in having Tencent on the share registry. It said: “Tencent’s investment provides us with the opportunity to learn from one of the world’s most successful digital platform businesses. To be able to tap into Tencent’s vast experience and network is valuable, as is the potential to collaborate in areas such as technology, geographic expansion and future payment options on the Afterpay platform.”
While I would say that Afterpay’s shares are probably fully valued now, I would still be a buyer if you plan to hold onto them for the long term.
Along with Altium Limited (ASX: ALU) and Appen Ltd (ASX: APX), I think Afterpay is one of the best tech shares on the Australian share market and believe it could generate strong returns for investors over the next decade.
Afterpay may no longer be dirt cheap, but these top ASX shares still look great value after the market crash.
5 cheap stocks that could be the biggest winners of the stock market crash
Investing expert Scott Phillips has just named what he believes are the 5 cheapest and best stocks to buy right now.
Courtesy of the crashing stock market, these 5 companies are suddenly trading at significant discounts to their recent highs… creating what could be incredible opportunities for bargain-hungry investors.
Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares to buy now… before the next stock market rally.
Returns as of 7/4/2020
More reading
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO, Altium, and Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post The Afterpay share price just hit a record high: Is it still a buy? appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2SVTm04
Bluebird bio Inc. (BLUE) said on Monday its partner Bristol Myers Squibb Co. (BMY) will pay $200 million to buy out future royalty obligations of its two jointly developed cancer therapies.Under the terms of an amended agreement, Bristol Myers will pay Bluebird bio to buy out future royalty obligations on outside of the U.S. sales for its two treatments, ide-cel and bb21217, which belong to a group of drugs called CAR T immunotherapy.“Our collaboration with Bluebird has resulted in the first CAR T cell therapy submitted for regulatory approval to target the B-cell maturation antigen and for multiple myeloma,” said Krishnan Viswanadhan, Senior Vice President, Global Cell Therapy Franchise Lead for Bristol Myers Squibb. “This amended partnership allows Bristol Myers Squibb to leverage our global manufacturing capabilities and consolidate all responsibilities outside the United States.”The companies will continue to equally share profits and losses in the U.S., Bluebird said. Furthermore, Bluebird announced that it is currently in the process of building out its wholly-owned manufacturing facility in Durham, North Carolina for the production of lentiviral vector (LVV) to support the U.S. commercial market for ide-cel and for Bluebird bio’s pipeline. Over time, Bristol Myers will assume responsibility for vector manufacturing outside of the U.S.Separately, Bluebird said its first-quarter net loss widened to $202.6 million from a loss of $164.4 million a year ago. Shares rose 1.5% to $60.19 in U.S. trading.Five-star analyst Raju Prasad at William Blair maintained his Hold rating on Bluebird’s stock, saying that he is taking a “wait-and-see approach on the company's expected commercial launches and earlier-stage programs”.“Although the revised collaboration with Bristol Myers provides $200 million in non-dilutive funding to Bluebird, allowing the company to extend its cash runway from 2021 to 2022, it was slightly below our estimates of the value of all ex-U.S. royalties,” Prasad said in a note to investors.Overall, Wall Street analysts have a Moderate Buy consensus rating on the stock based on 9 Buys and 4 Holds. The $108.75 average price target provides investors with 81% upside potential should the target be met in the next 12 months. (See Bluebird stock analysis on TipRanks).Related News: AstraZeneca, Daiichi Get FDA Breakthrough Status For Gastro Cancer Drug Seres Therapeutics Reports Weak Earnings, But Significant Upside Lies Ahead Inovio’s COVID-19 Vaccine Candidate Has the Edge Over Moderna’s, Says 5-Star Analyst More recent articles from Smarter Analyst: * Under Armour Sinks 10% on Weaker Second-Quarter Sales Outlook * Qantas Said to Halt Plane Deliveries From Boeing, Airbus Amid Travel Freeze * Debt-Laden Chesapeake Rolls Out $25 Million Incentive Executive Pay Plan * Microsoft to Splash $1.5 Billion on Italy's Cloud Business Transformation
from Yahoo Finance https://ift.tt/3fzbCGl

Luckily for income investors in this low interest rate environment, the Australian share market is home to a large number of dividend-paying shares.
While not all of these will be paying dividends during the pandemic, three that look set to do so are listed below.
Here’s why I think they could be good options for income investors right now:
I think that Coles is one of the safest dividend shares to buy. This is because, as we have seen in recent months, we still need the staples during a crisis. In addition to this, thanks to its positive growth outlook, I believe Coles is well-positioned to increase its dividend consistently over the coming years regardless of economic conditions. In FY 2021 I estimate that its shares will provide investors with a fully franked dividend yield of ~4%.
Another safe option to consider is Rural Funds. It is an agriculture-focused property group with a diverse portfolio of assets across a number of industries such as cattle, vineyards, and orchards. I like the company due to the quality of its assets and their long term tenancies. In respect to the latter, at the end of the first half its weighted average lease expiry stood at 11.5 years. This gives investors a lot of visibility with its earnings and distributions. In FY 2021 the company intends to lift its distribution to 11.28 cents per share. This works out to be a forward 5.9% distribution yield.
A final dividend share to consider buying is Wesfarmers. I think the conglomerate is a good option due to the quality and positive outlook of its portfolio of businesses. In addition to this, the company has a sizeable cash balance that could be used for acquisitions that bolster its growth in the coming years. At present I estimate that its shares offer a fully franked forward 3.9% dividend yield.
NEW: Expert names top dividend stock for 2020 (free report)
When our resident dividend expert Edward Vesely has a stock tip, it can pay to listen. After all, he’s the investing genius that runs Motley Fool Dividend Investor, the newsletter service that has picked huge winners like Dicker Data (+92%), SDI Limited (+53%) and National Storage (+35%).*
Edward has just named what he believes is the number one ASX dividend stock to buy for 2020.
This fully franked “under the radar” company is currently trading more than 24% below its all time high and paying a 6.7% grossed up dividend
The name of this dividend dynamo and the full investment case is revealed in this brand new free report.
But you will have to hurry — history has shown it can pay dividends to get in early to some of Edward’s stock picks, and this dividend stock is already on the move.
See the top dividend stock for 2020
*Returns as of 7/4/20
More reading
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended RURALFUNDS STAPLED. The Motley Fool Australia owns shares of COLESGROUP DEF SET and Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post 3 safe and strong ASX dividend shares to buy today appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2zpent7

Is the REA Group Limited (ASX: REA) share price a buy? Investors certainly thought so last week.
The REA Group share price rose 7.7% on the day that the third quarter trading update was released to the market. A strong reaction for the realstate.com.au owner.
The company said that in the three months to 31 March 2020, revenue rose by 1% to $199.8 million, earnings before interest, tax, depreciation and amortisation (EBITDA) went up 8% to $119.6 million, but free cash flow fell 20% to $66.7 million.
The property portal business also revealed how it has performed over the nine months to 31 March 2020. Revenue was down 4% to $640.2 million, EBITDA dropped 3% to $390.8 million and free cash flow was down 14% to $195.2 million.
It was a mixed quarter because the number of listings were actually showing improvement until halfway through March. In the first half of March national listings were up 3% with listing increases of 15% in Melbourne and 24% in Sydney, but finished down 2% after the impact of the coronavirus.
Overall national residential listings declined 7% for the quarter, while Melbourne and Sydney were up 6% and 5% respectively.
So what does this mean for the REA Group share price? Well, share prices are predominately forward looking. The above numbers and April’s listing numbers didn’t seem to put off investors.
In April, national residential listings were down 33%, Sydney listings were down 18% and Melbourne listings were down 27%. Perhaps investors were expecting worse.
The company is working to offset some of the lost revenue by implementing cost cutting measures. Reduced marketing expenditure and a review of all supplier arrangements. Fourth quarter core operating expenses are expected to be 20% lower than last year. It continues to achieve stronger viewing numbers than Domain Holdings Australia Ltd (ASX: DHG).
REA Group said it has a strong balance sheet, low debt levels and a cash balance of $135 million at 30 April 2020. It also added a $149 million loan facility as well as an additional $20 million overdraft facility.
The company is well placed to survive through this crisis. People will keep transacting property, particularly once the worst of the crisis is over.
At the current REA Group share price I think it could be a long-term buy. But there could be another painful drop in the next few weeks, so I’d only buy a small-ish REA Group position today.
However, these top ASX growth shares are perfectly priced for great buys today.
NEW! 5 Cheap Stocks With Massive Upside Potential
Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.
One is a diversified conglomerate trading 40% off it’s all time high, all while offering a fully franked dividend yield of over 3%…
Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.
Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.
Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.
But you will have to hurry because the cheap share prices on offer today might not last for long.
Returns as of 7/4/2020
More reading
Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has recommended REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Is the REA Group share price a buy? appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2Z5yFCX
from Yahoo Finance https://ift.tt/3fEpM98
from Yahoo Finance https://ift.tt/2Wlpe04

On Monday the S&P/ASX 200 Index (ASX: XJO) started the week in sensational form. The benchmark index stormed 1.3% higher to 5,461.2 points.
Will the market be able to build on this on Tuesday? Here are five things to watch:
It looks set to be a weaker day of trade for the Australian share market on Tuesday. According to the latest SPI futures, the ASX 200 is expected to fall 20 points or 0.4% at the open. This follows a mixed night of trade on Wall Street which saw the Dow Jones fall 0.45%, the S&P 500 trade flat, and the Nasdaq index jump 0.8%.
Energy producers such as Beach Energy Ltd (ASX: BPT) and Woodside Petroleum Limited (ASX: WPL) could be under pressure today after oil prices dropped lower. According to Bloomberg, the WTI crude oil price fell 0.8% to US$24.54 a barrel and the Brent crude oil price dropped 3.1% to US$30.97 a barrel. Oil prices dropped lower despite Saudi Arabia announcing plans to cut its production further.
Gold miners including Evolution Mining Ltd (ASX: EVN) and Newcrest Mining Limited (ASX: NCM) will be on watch after the gold price tumbled lower. According to CNBC, the spot gold price fell 0.75% to US$1,701.01 an ounce. Investors were buying the U.S. dollar ahead of gold on second wave fears.
The Incitec Pivot Ltd (ASX: IPL) share price will be on watch today when it returns from its trading halt. The chemicals company placed its shares in a trading halt on Monday after the release of its half year results and the launch of a $600 million capital raising. Incitec Pivot reported earnings before interest and tax (EBIT) of $159 million, up 34% on the prior corresponding period. In respect to its capital raising, it is aiming to raise its $600 million at $2.00 per new share. This represents an 8.7% discount to its last closing price.
The Cochlear Limited (ASX: COH) share price is overvalued according to analysts at Goldman Sachs. In response to its update on Monday which revealed that sales were down 60% in April because of the pandemic, Goldman Sachs has reiterated its sell rating and $156.00 price target. It commented: “Whilst elective surgeries appear to be resuming ahead of our expectations, the trajectory of recovery also appears to be shallower.”
NEW! 5 Cheap Stocks With Massive Upside Potential
Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer. One is a diversified conglomerate trading 40% off it’s all time high, all while offering a fully franked dividend yield of over 3%… Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.
Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.
Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.
But you will have to hurry because the cheap share prices on offer today might not last for long.
Returns as of 7/4/2020
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
More reading
The post 5 things to watch on the ASX 200 on Tuesday appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3dyc45R
Sorry if this is the wrong place to post this.
I'm thinking about getting started in the stock market but before I do I want to educate myself as much as possible. There's so much information out there – it's hard to know what to read. I'd like to ask you to share what books helped you when you were a beginner. Whether the topic was about mentality, strategy, mistakes, or not about investing – if it helped you become a better investor I'd like to know about it.
Thank you very much for your time!
submitted by /u/leedex
[link] [comments]